Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 8/20 | 1.00 |
| ▸ | NR4A1 | P22736 | 1/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 11/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 10/20 | 0.70 |
| ▸ | HPGD | P15428 | 10/20 | 0.70 |
| ▸ | CASP1 | P29466 | 9/20 | 0.70 |
| ▸ | CASP7 | P55210 | 9/20 | 0.70 |
| ▸ | HSD17B10 | Q99714 | 8/20 | 0.70 |
| ▸ | MEN1 | O00255 | 5/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.70 |
| ▸ | POLB | P06746 | 3/20 | 0.70 |
| ▸ | ESR1 | P03372 | 2/20 | 0.70 |
| ▸ | GAA | P10253 | 2/20 | 0.70 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.70 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.65 |
| ▸ | NPSR1 | Q6W5P4 | 4/20 | 0.63 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.63 |
| ▸ | BLM | P54132 | 1/20 | 0.63 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.63 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13401733 | 0.79 | KDM4E (1.00) | MAPTNR4A1KDM4EALDH1A1HPGD | |
| SCHEMBL13912173 | 0.77 | MAPK1 (1.00) | MAPTNR4A1KDM4EALDH1A1HPGD | |
| SCHEMBL4216951 | 0.76 | ALDH1A1 (0.71) | MAPTNR4A1KDM4EALDH1A1HPGD | |
| SCHEMBL4343184 | 0.74 | THRB (0.65) | MAPTNR4A1KDM4EALDH1A1HPGD | |
| SCHEMBL4204615 | 0.74 | HPGD (0.84) | MAPTKDM4EALDH1A1HPGDCASP1 | |
| SCHEMBL4216963 | 0.73 | HPGD (1.00) | MAPTNR4A1KDM4EALDH1A1HPGD | |
| SCHEMBL4206860 | 0.73 | HPGD (1.00) | MAPTNR4A1KDM4EALDH1A1HPGD | |
| SCHEMBL3714389 | 0.72 | KDM4E (0.72) | MAPTNR4A1KDM4EALDH1A1HPGD | |
| SCHEMBL4204320 | 0.72 | HPGD (0.84) | MAPTNR4A1KDM4EALDH1A1HPGD | |
| SCHEMBL14039099 | 0.72 | KDM4E (0.69) | MAPTNR4A1KDM4EALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090118135-A1 | METHODS AND COMPOUNDS FOR REGULATING APOPTOSIS | THE BURNHAM INSTITUTE (US) | 2009-05-07 | — | — | US | disclosed |
| US-20090118135-A1 | METHODS AND COMPOUNDS FOR REGULATING APOPTOSIS | THE BURNHAM INSTITUTE (US) | 2009-05-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090118135-A1 | METHODS AND COMPOUNDS FOR REGULATING APOPTOSIS | BCL2, BAX, BAD | MAPT 3866/4885NR4A1 4082/4885KDM4E 3373/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.